Skip to main content

The role of personalized medicine in pancreatic cancer

Intervista a Thomas Seufferlein By 29 Giugno 2024Luglio 1st, 2024No Comments
Dai congressi

What role do personalised medicine and precision medicine play in the management of pancreatic cancer? And what are the future prospects? We asked Thomas Seufferlein (Ärztlicher Direktor Klinik für Innere Medizin I – Universitätsklinikum Ulm), that we met at ESMO GI Congress 2024 in Munchen.